Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
0(0%)
Results Posted
80%(4 trials)
Terminated
1(14%)

Phase Distribution

Ph phase_1
2
29%
Ph phase_2
4
57%
Ph phase_4
1
14%

Phase Distribution

2

Early Stage

4

Mid Stage

1

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
2(28.6%)
Phase 2Efficacy & side effects
4(57.1%)
Phase 4Post-market surveillance
1(14.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

71.4%

5 of 7 finished

Non-Completion Rate

28.6%

2 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Completed(5)
Terminated(2)

Detailed Status

Completed5
Withdrawn1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
83.3%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (28.6%)
Phase 24 (57.1%)
Phase 41 (14.3%)

Trials by Status

withdrawn114%
terminated114%
completed571%

Recent Activity

0 active trials
Showing 5 of 7
completedphase_4

German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (05/93)

NCT00199069
terminatedphase_1

ABT-751 With Chemotherapy for Relapsed Pediatric ALL

NCT00439296
withdrawnphase_1

Study of 6-Thioguanine in Combination With 6-Mercaptopurine During Maintenance Therapy of Childhood Lymphoma

NCT02141100
completedphase_2

Study of Sequential Administration of Oral 6-Thioguanine After Methotrexate in Patients With LCH

NCT00588536
completedphase_2

CINJALL: Treatment for Children With Acute Lymphocytic Leukemia

NCT00176462
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT00199069Phase 4

German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (05/93)

Completed
NCT00439296Phase 1

ABT-751 With Chemotherapy for Relapsed Pediatric ALL

Terminated
NCT02141100Phase 1

Study of 6-Thioguanine in Combination With 6-Mercaptopurine During Maintenance Therapy of Childhood Lymphoma

Withdrawn
NCT00588536Phase 2

Study of Sequential Administration of Oral 6-Thioguanine After Methotrexate in Patients With LCH

Completed
NCT00176462Phase 2

CINJALL: Treatment for Children With Acute Lymphocytic Leukemia

Completed
NCT00504660Phase 2

6-TG, Capecitabine and Celecoxib Plus TMZ or CCNU for Anaplastic Glioma Patients

Completed
NCT00587873Phase 2

Sequential Administration of Oral 6-Thioguanine (6-TG) After Methotrexate (MTX) in Patients With Relapsed Hodgkin's Disease (Phase II)

Completed

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7